Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 3/2015

01.03.2015 | Head and Neck

Survivin expression correlates with nodal metastasis in T1–T2 squamous cell carcinoma of the tongue

verfasst von: Murat Doğan, Sedat Çağlı, İmdat Yüce, Ali Bayram, Mehmet Akif Somdaş, Duran Karataş, Mehmet Celalettin Cihan, Fatih Yüksel, Ercihan Güney

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

In this study, the correlation between neck metastasis and recurrence was investigated by studying specimens of tongue squamous cell carcinoma patients immunohistochemical with survivin antibodies in the primary biopsy. A retrospective review was conducted at the Academic University Hospital. 46 patients who had squamous cell carcinoma of the tongue, who underwent various types of glossectomy and neck dissections between 1991 and 2008, were evaluated. The patient’s sex, TNM staging, differentiation and recurrence rates were analyzed. There were 20 T1 patients and 26 T2 patients; 27 of the patients were N0 and 19 had metastatic lymph nodes in the neck. Survivin antibodies were applied with streptavidin–biotin method to the sections that were prepared from the primary tumor biopsy specimens of the patients. The correlation between neck metastasis and recurrence and survivins’ immunohistochemical staining was analyzed with statistical methods. There were no significant differences between the patient’s age, sex, tumor’s T stage, tumor differentiation and survivin staining density. Survivin staining was positive in 15 (79 %) of 19 patients with neck metastasis, while it was positive in 16 (59 %) of 27 patients without neck metastasis. Eleven (79 %) of the 14 patients who had recurrence and all 6 patients who had neck recurrence only were stained by survivin. Expression of nuclear and cytoplasmic survivin can be a useful marker for predicting cervical lymph node metastasis in T1–T2 tumors in tongue SCC.
Literatur
1.
Zurück zum Zitat Johnson JT, Barnes EL, Myers EN, Schramm VL, Borochovitz D, Sigler BA (1981) The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 107:725–729CrossRefPubMed Johnson JT, Barnes EL, Myers EN, Schramm VL, Borochovitz D, Sigler BA (1981) The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 107:725–729CrossRefPubMed
2.
Zurück zum Zitat Dias FL, Kligerman J, Matos de Sa G, Arcuri RA, Freitas EQ, Farias T, Matos F, Lima RA (2001) Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 125:23–29CrossRefPubMed Dias FL, Kligerman J, Matos de Sa G, Arcuri RA, Freitas EQ, Farias T, Matos F, Lima RA (2001) Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 125:23–29CrossRefPubMed
3.
Zurück zum Zitat Ho CM, Lam KH, Wei WI, Lau SK, Lam LK (1992) Occult lymph node metastasis in small oral tongue cancers. Head Neck 14:359–363CrossRefPubMed Ho CM, Lam KH, Wei WI, Lau SK, Lam LK (1992) Occult lymph node metastasis in small oral tongue cancers. Head Neck 14:359–363CrossRefPubMed
4.
Zurück zum Zitat Yamazaki H, Inoue T, Yoshida K, Tanaka E, Yoshioka Y, Nakamura H, Furukawa S, Shimizutani K (2004) Lymph node metastasis of early oral tongue cancer after interstitial radiotherapy. Int J Radiation Oncol Biol Phys 58:139–146CrossRef Yamazaki H, Inoue T, Yoshida K, Tanaka E, Yoshioka Y, Nakamura H, Furukawa S, Shimizutani K (2004) Lymph node metastasis of early oral tongue cancer after interstitial radiotherapy. Int J Radiation Oncol Biol Phys 58:139–146CrossRef
5.
Zurück zum Zitat Ferreira CG, Van der Valk P, Span SW, Ludwig I, Smit EF, Kruyt FAE, Pinedo HM, Van Tinteren H, Giaccone G (2001) Expression of X-linked inhibitor of apoptosis as a novel prognostic marker İn radically resected non-small cell lung cancer patients. Clin Cancer Res 7:2468–2474PubMed Ferreira CG, Van der Valk P, Span SW, Ludwig I, Smit EF, Kruyt FAE, Pinedo HM, Van Tinteren H, Giaccone G (2001) Expression of X-linked inhibitor of apoptosis as a novel prognostic marker İn radically resected non-small cell lung cancer patients. Clin Cancer Res 7:2468–2474PubMed
6.
Zurück zum Zitat Imoto I, Tsuda H, Hirasawa A, Miura M, Sakamoto M, Hirohashi S, Inazawa J (2002) Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy. Cancer Res 62:4860–4866PubMed Imoto I, Tsuda H, Hirasawa A, Miura M, Sakamoto M, Hirohashi S, Inazawa J (2002) Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy. Cancer Res 62:4860–4866PubMed
7.
Zurück zum Zitat Liu SS, Tsang BK, Cheung ANY, Xue WC, Cheng DKL, Ng TY, Wong LC, Ngan HYS (2001) Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. Eur J Cancer 37:1104–1110CrossRefPubMed Liu SS, Tsang BK, Cheung ANY, Xue WC, Cheng DKL, Ng TY, Wong LC, Ngan HYS (2001) Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. Eur J Cancer 37:1104–1110CrossRefPubMed
8.
Zurück zum Zitat Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M, Takano Y (2001) Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163:109–116CrossRefPubMed Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M, Takano Y (2001) Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163:109–116CrossRefPubMed
9.
Zurück zum Zitat Tanimoto T, Tsuda H, Imazeki N, Ohno Y, Imoto I, Inazawa J, Matsubara O (2005) Nuclear expression of cIAP–1, an apoptosis inhibiting protein, predicts lymph node metastasis and poor patient prognosis in head and neck squamous cell carcinomas. Cancer Lett 224:141–151CrossRefPubMed Tanimoto T, Tsuda H, Imazeki N, Ohno Y, Imoto I, Inazawa J, Matsubara O (2005) Nuclear expression of cIAP–1, an apoptosis inhibiting protein, predicts lymph node metastasis and poor patient prognosis in head and neck squamous cell carcinomas. Cancer Lett 224:141–151CrossRefPubMed
10.
Zurück zum Zitat Imoto I, Yang ZQ, Pimkhaokham A, Tsuda H, Shimada Y, Imamura M, Ohki M, Inazawa J (2001) Identification of cIAP–1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res 61:6629–6634PubMed Imoto I, Yang ZQ, Pimkhaokham A, Tsuda H, Shimada Y, Imamura M, Ohki M, Inazawa J (2001) Identification of cIAP–1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res 61:6629–6634PubMed
11.
Zurück zum Zitat Liston P, Fong WG, Korneluk RG (2003) The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22:8568–8580CrossRefPubMed Liston P, Fong WG, Korneluk RG (2003) The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22:8568–8580CrossRefPubMed
12.
Zurück zum Zitat Salvesen GS, Duckett CS (2002) IAP proteins: blocking the road to death’s door. NatRevMol Cell Biol 3:401–410 Salvesen GS, Duckett CS (2002) IAP proteins: blocking the road to death’s door. NatRevMol Cell Biol 3:401–410
13.
Zurück zum Zitat Reed JC, Doctor KS, Godzik A (2004) The domains of apoptosis: a genomics perspective. Sci STKE 22:91–99 Reed JC, Doctor KS, Godzik A (2004) The domains of apoptosis: a genomics perspective. Sci STKE 22:91–99
14.
Zurück zum Zitat Rothe M, Pan MG, Henzel WJ, Ayers TM, Goeddel DV (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243–1252CrossRefPubMed Rothe M, Pan MG, Henzel WJ, Ayers TM, Goeddel DV (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243–1252CrossRefPubMed
15.
Zurück zum Zitat Hu SM, Yang XL (2003) Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J BiolChem 278:10055–10060 Hu SM, Yang XL (2003) Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J BiolChem 278:10055–10060
16.
Zurück zum Zitat Li XM, Yang YL, Ashwell JD (2002) TNFRII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416:345–349CrossRefPubMed Li XM, Yang YL, Ashwell JD (2002) TNFRII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416:345–349CrossRefPubMed
17.
Zurück zum Zitat Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921CrossRefPubMed Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921CrossRefPubMed
18.
Zurück zum Zitat Lu CD, Altieri DC, Tanigawa N (1998) Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. CancerRes 58:1808–1812 Lu CD, Altieri DC, Tanigawa N (1998) Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. CancerRes 58:1808–1812
19.
Zurück zum Zitat Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predict shorter survival rates in colorectal cancer. Cancer Res 58:5071–5074PubMed Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predict shorter survival rates in colorectal cancer. Cancer Res 58:5071–5074PubMed
20.
Zurück zum Zitat Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC (1998) Develop mentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 152:43–49PubMedCentralPubMed Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC (1998) Develop mentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 152:43–49PubMedCentralPubMed
21.
Zurück zum Zitat Leemans CR, Tiwari R, Nauta JJ, Snow GB (1991) Discontinuous vs in-continuity neck dissection of the oral cavity. Arch Otolaryngol Head Neck Surg 117(9):1003–1006CrossRefPubMed Leemans CR, Tiwari R, Nauta JJ, Snow GB (1991) Discontinuous vs in-continuity neck dissection of the oral cavity. Arch Otolaryngol Head Neck Surg 117(9):1003–1006CrossRefPubMed
22.
Zurück zum Zitat Pimenta Amaral TM, Da Silva Freire AR, Carvalho AL, Pinto CA, Kowalski LP (2004) Predictive factors of occult metastasis and pognosis of clinical stages I and II squamous cell carcinoma of the tongue and flor of the mouth. Oral Oncol 40:780–786CrossRefPubMed Pimenta Amaral TM, Da Silva Freire AR, Carvalho AL, Pinto CA, Kowalski LP (2004) Predictive factors of occult metastasis and pognosis of clinical stages I and II squamous cell carcinoma of the tongue and flor of the mouth. Oral Oncol 40:780–786CrossRefPubMed
23.
Zurück zum Zitat Ataula S, Grenman R, Laippala P, Syrjanen S (1996) Cancer of the tongue in patients younger than 40 years. Arch Otolaryngol. Head Neck Surg 122:1313–1319CrossRef Ataula S, Grenman R, Laippala P, Syrjanen S (1996) Cancer of the tongue in patients younger than 40 years. Arch Otolaryngol. Head Neck Surg 122:1313–1319CrossRef
24.
Zurück zum Zitat Sanderson RJ, Ironside JA (2002) Squamous cell carcinoma of the head and neck. Br Med J 325:822–827CrossRef Sanderson RJ, Ironside JA (2002) Squamous cell carcinoma of the head and neck. Br Med J 325:822–827CrossRef
25.
Zurück zum Zitat Okamoto M, Nishimine M, Kishi M, Kirita T, Sugimura M (2002) Prediction of delayed neck metastasis in patient stage I–II squamous cell carcinoma of the tongue. J Oral Pathol Med 31:227–233CrossRefPubMed Okamoto M, Nishimine M, Kishi M, Kirita T, Sugimura M (2002) Prediction of delayed neck metastasis in patient stage I–II squamous cell carcinoma of the tongue. J Oral Pathol Med 31:227–233CrossRefPubMed
26.
Zurück zum Zitat Kaneko S, Yoshimura T, Ikemura K, Shirasuna K, Kusukawa J, Ohishi M et al (2002) Primary neck management among patients with cancer or the oral cavity without clinical nodal metastases: a decision and sensitivity analysis. Head Neck 24(6):582–590CrossRefPubMed Kaneko S, Yoshimura T, Ikemura K, Shirasuna K, Kusukawa J, Ohishi M et al (2002) Primary neck management among patients with cancer or the oral cavity without clinical nodal metastases: a decision and sensitivity analysis. Head Neck 24(6):582–590CrossRefPubMed
27.
Zurück zum Zitat Kırıta T, Okabe S, İzumo T, Sugimura M (1995) Risk factors of the postoperative local recurrence of tongue carcinoma. J Oral Maxillofac Surg 52:149–1543 Kırıta T, Okabe S, İzumo T, Sugimura M (1995) Risk factors of the postoperative local recurrence of tongue carcinoma. J Oral Maxillofac Surg 52:149–1543
28.
Zurück zum Zitat Gold KA, Kim ES (2009) Role of molecular markers and gene profiling in Head and Neck Cancers. Curr Opin Oncol 21:206–211CrossRefPubMed Gold KA, Kim ES (2009) Role of molecular markers and gene profiling in Head and Neck Cancers. Curr Opin Oncol 21:206–211CrossRefPubMed
29.
Zurück zum Zitat Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S et al (2008) Platinum based chemothrapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1127CrossRefPubMed Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S et al (2008) Platinum based chemothrapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1127CrossRefPubMed
30.
Zurück zum Zitat Marioni G, Bedogni A, Giacomelli L, Ferraro SM, Bertolin A, Facco E, Staffieri A, Marino F (2005) Survivin expression is significantly higher in pN + oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas. Acta Oto-Larnygologica 125:1218–1223CrossRef Marioni G, Bedogni A, Giacomelli L, Ferraro SM, Bertolin A, Facco E, Staffieri A, Marino F (2005) Survivin expression is significantly higher in pN + oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas. Acta Oto-Larnygologica 125:1218–1223CrossRef
31.
Zurück zum Zitat Span PN, Sweep FC, Wiegerinck ET, Tjan-Heijnen VC, Manders P, Beex LV, de Kok JB (2004) Survivin is an independent prognostic marker for risk stratification of breast cancer patients. ClinChem Nov;50(11):1986–1993 Span PN, Sweep FC, Wiegerinck ET, Tjan-Heijnen VC, Manders P, Beex LV, de Kok JB (2004) Survivin is an independent prognostic marker for risk stratification of breast cancer patients. ClinChem Nov;50(11):1986–1993
32.
Zurück zum Zitat Zhang Y, Huang D, Yu G (2005) Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas. Acta Oto-Laryngol 125:1345–1350CrossRef Zhang Y, Huang D, Yu G (2005) Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas. Acta Oto-Laryngol 125:1345–1350CrossRef
33.
Zurück zum Zitat Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I (2002) Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma. Int J Mol Med 10:211–216PubMed Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I (2002) Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma. Int J Mol Med 10:211–216PubMed
34.
Zurück zum Zitat Muzio LL, Staibano S, Pannone G, Mignogna MD, Mariggio A, Salvatore G, Chieffi P, Tramontano D, De Rosa G, Altieri DC (2001) Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. ExpMol Pathol 70:249–254 Muzio LL, Staibano S, Pannone G, Mignogna MD, Mariggio A, Salvatore G, Chieffi P, Tramontano D, De Rosa G, Altieri DC (2001) Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. ExpMol Pathol 70:249–254
35.
Zurück zum Zitat Sohn DM, Kim SY, Baek MJ, Lim CW, Lee MH, Cho MS, Kim TY (2006) Expression of survivin and clinical correlation in patient with breast cancer. Biomed Pharmacother 60:289–292CrossRefPubMed Sohn DM, Kim SY, Baek MJ, Lim CW, Lee MH, Cho MS, Kim TY (2006) Expression of survivin and clinical correlation in patient with breast cancer. Biomed Pharmacother 60:289–292CrossRefPubMed
36.
Zurück zum Zitat Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC, Molina TJ (2000) Prognostic significance of survivin expression in diffuse large B cell lymphomas. Blood 96:1921–1925PubMed Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC, Molina TJ (2000) Prognostic significance of survivin expression in diffuse large B cell lymphomas. Blood 96:1921–1925PubMed
37.
Zurück zum Zitat Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, Martin C, Font A, Barnadas A, Abad A (1999) A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J ClinOncol 17:2100–2104 Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, Martin C, Font A, Barnadas A, Abad A (1999) A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J ClinOncol 17:2100–2104
38.
Zurück zum Zitat Samuel T, Okada K, Hyer M, Welsh K, Zapata JM, Reed JC (2005) cIAP1 localizes to the nuclear compartment and modulates the cell cycle. CancerRes 65:210–218 Samuel T, Okada K, Hyer M, Welsh K, Zapata JM, Reed JC (2005) cIAP1 localizes to the nuclear compartment and modulates the cell cycle. CancerRes 65:210–218
39.
Zurück zum Zitat Ribeiro DA, Kitakawa D, Domingues MA, Cabral LA, Marques ME, Salvadori DM (2007) Survivin and inducible nitricoxide synthase production during 4NQO-induced rat tongue carcinogenesis. Exp. And Mol. Pathol 83:131–137CrossRef Ribeiro DA, Kitakawa D, Domingues MA, Cabral LA, Marques ME, Salvadori DM (2007) Survivin and inducible nitricoxide synthase production during 4NQO-induced rat tongue carcinogenesis. Exp. And Mol. Pathol 83:131–137CrossRef
40.
Zurück zum Zitat Jinbu Y, Tsukinoki K, Myagi N, Senna T, Obi Y, Matsumoto K, Noguchi T, Kusama M (2006) Expression of Survivin in Oral Squamous Cell Carcinoma. Oral Med Pathol 11:41–44CrossRef Jinbu Y, Tsukinoki K, Myagi N, Senna T, Obi Y, Matsumoto K, Noguchi T, Kusama M (2006) Expression of Survivin in Oral Squamous Cell Carcinoma. Oral Med Pathol 11:41–44CrossRef
41.
Zurück zum Zitat Marioni G, Bedogni A, Giacomelli L, Ferraro SM (2005) Survivin expression is significantly higher in pN oral and oropharyngeal primary squamous cell carcinomas than in pNo carcinomas. Acta Otolaryngol 125:1218–1223CrossRefPubMed Marioni G, Bedogni A, Giacomelli L, Ferraro SM (2005) Survivin expression is significantly higher in pN oral and oropharyngeal primary squamous cell carcinomas than in pNo carcinomas. Acta Otolaryngol 125:1218–1223CrossRefPubMed
42.
Zurück zum Zitat Qi S, Mogi S, Tsuda H, Tanaka Y, Kozaki K, Imoto I, Inazawa J, Hasegawa S, Omura K (2008) Expression of cIAP–1 correlates with nodal metastasis in squamous cell carcinoma of the tongue. Int J Oral Maxillofac Surg 37:1047–1053CrossRefPubMed Qi S, Mogi S, Tsuda H, Tanaka Y, Kozaki K, Imoto I, Inazawa J, Hasegawa S, Omura K (2008) Expression of cIAP–1 correlates with nodal metastasis in squamous cell carcinoma of the tongue. Int J Oral Maxillofac Surg 37:1047–1053CrossRefPubMed
43.
Zurück zum Zitat Kim YH, Kim SM, Kim YK, Hong SP, Kim MJ, Myoung H (2010) Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma. J Oral Pathol Med 39:368–375PubMed Kim YH, Kim SM, Kim YK, Hong SP, Kim MJ, Myoung H (2010) Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma. J Oral Pathol Med 39:368–375PubMed
44.
Zurück zum Zitat Pickhard A, Gröber S, Haug A, Piontek G, Wirth M, Straßen U, Rudelius M, Reiter R (2014) Survivin and p-Akt as potential prognostic markers in squamous cell carcinoma of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol. doi:10.1016/j.oooo.2014.02.005 PubMed Pickhard A, Gröber S, Haug A, Piontek G, Wirth M, Straßen U, Rudelius M, Reiter R (2014) Survivin and p-Akt as potential prognostic markers in squamous cell carcinoma of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol. doi:10.​1016/​j.​oooo.​2014.​02.​005 PubMed
Metadaten
Titel
Survivin expression correlates with nodal metastasis in T1–T2 squamous cell carcinoma of the tongue
verfasst von
Murat Doğan
Sedat Çağlı
İmdat Yüce
Ali Bayram
Mehmet Akif Somdaş
Duran Karataş
Mehmet Celalettin Cihan
Fatih Yüksel
Ercihan Güney
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 3/2015
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-014-3009-3

Weitere Artikel der Ausgabe 3/2015

European Archives of Oto-Rhino-Laryngology 3/2015 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

HNO-Op. auch mit über 90?

16.04.2024 HNO-Chirurgie Nachrichten

Mit Blick auf das Risiko für Komplikationen nach elektiven Eingriffen im HNO-Bereich scheint das Alter der Patienten kein ausschlaggebender Faktor zu sein. Entscheidend ist offenbar, wie fit die Betroffenen tatsächlich sind.

Intrakapsuläre Tonsillektomie gewinnt an Boden

16.04.2024 Tonsillektomie Nachrichten

Gegenüber der vollständigen Entfernung der Gaumenmandeln hat die intrakapsuläre Tonsillektomie einige Vorteile, wie HNO-Fachleute aus den USA hervorheben. Sie haben die aktuelle Literatur zu dem Verfahren gesichtet.

Bilateraler Hörsturz hat eine schlechte Prognose

15.04.2024 Hörsturz Nachrichten

Die Mehrzahl der Menschen mit Hörsturz ist einseitig betroffen, doch auch ein beidseitiger Hörsturz ist möglich. Wie häufig solche Fälle sind und wie sich ihr Verlauf darstellt, hat eine HNO-Expertenrunde aus den USA untersucht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.